Home NDC 64679-793-01 Imatinib Mesylate
Product NDC 64679-793
Requested package NDC 64679-793-01
11-digit product format 646790793
Labeler code 64679
Product ID 64679-793_016beab4-925a-4cb0-b994-cd0ba0419879
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name imatinib mesylate
Dosage form TABLET
Route ORAL
Labeler Wockhardt USA LLC.
Application ANDA208429
Marketing category ANDA
Marketing start 2019-01-17
Marketing end 0000-00-00
Substance IMATINIB MESYLATE
Active strength 100 mg/1
Pharmacologic classes Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 15 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Code, Status table Captured / source date Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A208429-001 IMATINIB MESYLATE IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2019-01-17 A208429-002 IMATINIB MESYLATE IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2019-01-17
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A208429-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2019-01-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A208429-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2019-01-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A208429-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2019-01-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A208429-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2019-01-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A208429-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2019-01-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A208429-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2019-01-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A208429-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2019-01-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A208429-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2019-01-17 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A208429-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2019-01-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A208429-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2019-01-17 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A208429-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2019-01-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A208429-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2019-01-17 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A208429-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2019-01-17 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A208429-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2019-01-17 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A208429-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2019-01-17 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A208429-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2019-01-17 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A208429-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2019-01-17 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A208429-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2019-01-17 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A208429-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2019-01-17 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A208429-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2019-01-17 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A208429-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2019-01-17 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A208429-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2019-01-17 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A208429-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2019-01-17 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A208429-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2019-01-17 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A208429-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2019-01-17 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A208429-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2019-01-17 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A208429-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2019-01-17 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A208429-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2019-01-17 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A208429-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2019-01-17 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A208429-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2019-01-17 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A208429-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2019-01-17 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A208429-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2019-01-17 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A208429-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2019-01-17 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A208429-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2019-01-17 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A208429-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2019-01-17 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A208429-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2019-01-17 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A208429-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2019-01-17 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A208429-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2019-01-17 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A208429-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2019-01-17 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A208429-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2019-01-17 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 82 observed states.
FDA-Initiated Inactive NDC Indexing# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 64679-793-01 64679079301 30 TABLET in 1 BOTTLE (64679-793-01) 30 tablet 2019-01-17 0000-00-00 No No Current